Pseudoprogression and Pseudoresponse in the Management of High-Grade Glioma : Optimal Decision Timing According to the Response Assessment of the Neuro-Oncology Working Group
Ji Hyun Chang, Chae-Yong Kim, Byung Se Choi, Yu Jung Kim, Jae Sung Kim, In Ah Kim
J Korean Neurosurg Soc. 2014;55(1):5-11.   Published online 2014 Jan 31     DOI: https://doi.org/10.3340/jkns.2014.55.1.5
Citations to this article as recorded by Crossref logo
Identification of prognostic risk score of disulfidptosis-related genes and molecular subtypes in glioma
Qian Jiang, Guo-Yuan Ling, Jun Yan, Ju-Yuan Tan, Ren-Bao Nong, Jian-Wen Li, Teng Deng, Li-Gen Mo, Qian-Rong Huang
Biochemistry and Biophysics Reports.2024; 37: 101605.     CrossRef
Surgical management of Glioma Grade 4: technical update from the neuro-oncology section of the Italian Society of Neurosurgery (SINch®): a systematic review
Tamara Ius, Giovanni Sabatino, Pier Paolo Panciani, Marco Maria Fontanella, Roberta Rudà, Antonella Castellano, Giuseppe Maria Vincenzo Barbagallo, Francesco Belotti, Riccardo Boccaletti, Giuseppe Catapano, Gabriele Costantino, Alessandro Della Puppa, Fra
Journal of Neuro-Oncology.2023; 162(2): 267.     CrossRef
Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review
Clara Le Fèvre, Benoît Lhermitte, Guido Ahle, Isabelle Chambrelant, Hélène Cebula, Delphine Antoni, Audrey Keller, Roland Schott, Alicia Thiery, Jean-Marc Constans, Georges Noël
Critical Reviews in Oncology/Hematology.2021; 157: 103188.     CrossRef
Pseudoprogression versus true progression in glioblastoma patients: A multiapproach literature review. Part 2 – Radiological features and metric markers
Clara Le Fèvre, Jean-Marc Constans, Isabelle Chambrelant, Delphine Antoni, Caroline Bund, Benjamin Leroy-Freschini, Roland Schott, Hélène Cebula, Georges Noël
Critical Reviews in Oncology/Hematology.2021; 159: 103230.     CrossRef
Assessment of the effect of therapy in a rat model of glioblastoma using [18F]FDG and [18F]FCho PET compared to contrast-enhanced MRI
Julie Bolcaen, Benedicte Descamps, Karel Deblaere, Filip De Vos, Tom Boterberg, Giorgio Hallaert, Caroline Van den Broecke, Christian Vanhove, Ingeborg Goethals, Pierpaolo Alongi
PLOS ONE.2021; 16(3): e0248193.     CrossRef
A Clinical PET Imaging Tracer ([18F]DASA-23) to Monitor Pyruvate Kinase M2–Induced Glycolytic Reprogramming in Glioblastoma
Corinne Beinat, Chirag B. Patel, Tom Haywood, Surya Murty, Lewis Naya, Jessa B. Castillo, Samantha T. Reyes, Megan Phillips, Pablo Buccino, Bin Shen, Jun Hyung Park, Mary Ellen I. Koran, Israt S. Alam, Michelle L. James, Dawn Holley, Kim Halbert, Harsh Ga
Clinical Cancer Research.2021; 27(23): 6467.     CrossRef
FDPS promotes glioma growth and macrophage recruitment by regulating CCL20 via Wnt/β‐catenin signalling pathway
Zhuo Chen, Guangyong Chen, Hang Zhao
Journal of Cellular and Molecular Medicine.2020; 24(16): 9055.     CrossRef
Blood Biomarkers of Glioma in Response Assessment Including Pseudoprogression and Other Treatment Effects: A Systematic Review
Istafa J. Raza, Campbell A. Tingate, Panagiota Gkolia, Lorena Romero, Jin W. Tee, Martin K. Hunn
Frontiers in Oncology.2020;[Epub]     CrossRef
The Path Toward PET-Guided Radiation Therapy for Glioblastoma in Laboratory Animals: A Mini Review
Sam Donche, Jeroen Verhoeven, Benedicte Descamps, Julie Bolcaen, Karel Deblaere, Tom Boterberg, Caroline Van den Broecke, Christian Vanhove, Ingeborg Goethals
Frontiers in Medicine.2019;[Epub]     CrossRef
Interval brain imaging for adults with cerebral glioma
Gerard Thompson, Theresa A Lawrie, Ashleigh Kernohan, Michael D Jenkinson
Cochrane Database of Systematic Reviews.2019;[Epub]     CrossRef
Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response
Maikel Verduin, Inge Compter, Danny Steijvers, Alida A. Postma, Daniëlle B. P. Eekers, Monique M. Anten, Linda Ackermans, Mark ter Laan, Ralph T. H. Leijenaar, Tineke van de Weijer, Vivianne C. G. Tjan-Heijnen, Ann Hoeben, Marc Vooijs
Disease Markers.2018; 2018: 1.     CrossRef
Treatment-related changes in glioblastoma: a review on the controversies in response assessment criteria and the concepts of true progression, pseudoprogression, pseudoresponse and radionecrosis
P. D. Delgado-López, E. Riñones-Mena, E. M. Corrales-García
Clinical and Translational Oncology.2018; 20(8): 939.     CrossRef
Current concepts in radiologic assessment of pediatric brain tumors during treatment, part 1
Felice D’Arco, Sinead Culleton, Laurens J. L. De Cocker, Kshitij Mankad, Jorge Davila, Benita Tamrazi
Pediatric Radiology.2018; 48(13): 1833.     CrossRef
Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma
Fernando Carceller, Lucy A. Fowkes, Komel Khabra, Lucas Moreno, Frank Saran, Anna Burford, Alan Mackay, David T. W. Jones, Volker Hovestadt, Lynley V. Marshall, Sucheta Vaidya, Henry Mandeville, Neil Jerome, Leslie R. Bridges, Ross Laxton, Safa Al-Sarraj,
Journal of Neuro-Oncology.2016; 129(1): 109.     CrossRef
Advanced Magnetic Resonance Imaging Methods for Planning and Monitoring Radiation Therapy in Patients With High-Grade Glioma
Seminars in Radiation Oncology.2014; 24(4): 248.     CrossRef